Literature DB >> 8420328

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis.

D W Branch1, G M Rodgers.   

Abstract

OBJECTIVE: The hypothesis of our study is that antiphospholipid antibodies predispose to thrombosis by inducing endothelial cell tissue factor expression. STUDY
DESIGN: Monolayers of cultured human umbilical vein endothelial cells were incubated for 8 hours in a medium containing 20% serum obtained either from patients with antiphospholipid antibodies (n = 11) or normal subjects (n = 8). Similar incubations were performed with immunoglobulin G fractions from either patients with antiphospholipid antibodies (n = 3) or normal subjects (n = 3). Endothelial cell tissue factor expression was measured with a tissue factor-specific chromogenic substrate assay. The results were analyzed with a two-tailed t test.
RESULTS: The mean endothelial cell tissue factor expression induced by antiphospholipid sera was significantly greater than the controls (p < 0.02). Immunoglobulin experiments indicated that the factor(s) responsible for the induction of tissue factor expression resides in the immunoglobulin G fraction of the sera (p < 0.01).
CONCLUSIONS: Endothelial cell tissue factor expression is induced by antiphospholipid sera, with activity residing at least in part in the immunoglobulin fraction. The induction of tissue factor by antiphospholipid sera may play a role in the thrombotic tendency observed in patients with antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420328     DOI: 10.1016/s0002-9378(12)90915-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

Review 1.  Intravenous immunoglobulin therapy in antiphospholipid syndrome.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

3.  Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α.

Authors:  Anne Hollerbach; Nadine Müller-Calleja; Antje Canisius; Carolin Orning; Karl J Lackner
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

4.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset.

Authors:  N Nakamura; T Ban; K Yamaji; Y Yoneda; Y Wada
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 6.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

7.  Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway.

Authors:  Venkaiah Betapudi; George Lominadze; Linda Hsi; Belinda Willard; Meifang Wu; Keith R McCrae
Journal:  Blood       Date:  2013-08-16       Impact factor: 22.113

8.  Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.

Authors:  Shruti Chaturvedi; Erin Cockrell; Ricardo Espinola; Linda Hsi; Stacey Fulton; Mohammad Khan; Liang Li; Fabio Fonseca; Suman Kundu; Keith R McCrae
Journal:  Thromb Res       Date:  2014-11-15       Impact factor: 3.944

9.  Immunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome.

Authors:  Anush Martirosyan; Martin Petrek; Amit Kishore; Gayane Manukyan
Journal:  Exp Ther Med       Date:  2016-06-08       Impact factor: 2.447

Review 10.  Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.

Authors:  Chieko Mineo
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.